HomeIndustry News › Hormones

Hormone replacement therapy: What doctors want women to know about HRT – ABC7 Los Angeles

Hormones: Hormone replacement therapy: What doctors want women to know about HRT – ABC7 Los Angeles

As menopause awareness grows, doctors are emphasizing what women should understand about hormone replacement therapy (HRT), according to medical experts interviewed by ABC7 Los Angeles. Healthcare providers report that misconceptions about HRT continue to prevent many women from accessing treatment that could significantly improve their quality of life during perimenopause and menopause.

Physicians stress that HRT remains the most effective treatment for managing common menopausal symptoms including hot flashes, night sweats, mood changes, and sleep disturbances. The therapy works by supplementing declining levels of estrogen and progesterone that occur naturally as women age. Despite its proven benefits, many women remain hesitant due to outdated concerns about safety risks that have since been clarified by more recent research.

Medical professionals point to the importance of individualized treatment plans, noting that HRT isn’t a one-size-fits-all solution. Factors including a woman’s age, time since menopause onset, personal medical history, and family history all play crucial roles in determining whether HRT is appropriate and which formulation might work best. Doctors also highlight that starting HRT closer to menopause onset, typically before age 60 or within 10 years of menopause, appears to offer the most favorable benefit-to-risk ratio.

The renewed focus on HRT education comes as healthcare providers recognize that menopausal symptoms can significantly impact work performance, relationships, and overall wellbeing—yet many women suffer in silence. Experts encourage women experiencing menopausal symptoms to have candid conversations with their healthcare providers about all available treatment options, including both hormonal and non-hormonal approaches. By understanding the current evidence and their individual risk factors, women can make informed decisions about managing this natural life transition.

← Previous Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S. - Eli Lilly Next → One in 10 people may have resistance to GLP-1 diabetes drugs - Stanford Medicine

Get the Weekly Digest

Research highlights, community picks, and expert insights — every week.

← Back to All News

Popular telehealth providers in this space

Disclosure: The links below are affiliate links — if you click through and make a purchase, GLPbase may earn a small commission at no additional cost to you. This section does not constitute medical advice or a recommendation to seek treatment. Any healthcare decisions are solely between you and your provider. These links do not affect the article above, which is independently researched and written before any affiliate links are added. Our editorial team does not receive commissions, and our analysis is never influenced by affiliate partnerships. For more details, see our Editorial Policy.